Creative Touch Permanent Makeup and Aesthetics

Cysteine is a conditionally essential amino acid – the body can synthesise it from methionine via the transsulphuration pathway, but this synthesis can become insufficient during physiological stress, illness, or inadequate dietary protein intake. Its chemistry is defined by a thiol group (–SH) on its side chain: a sulphur atom bonded to hydrogen that can donate or accept electrons, form covalent bonds with other thiol groups, and participate in redox reactions. These properties make cysteine biochemically versatile in ways that most amino acids are not – it acts as a structural cross-linker in keratin proteins, a direct antioxidant, and the rate-limiting precursor for glutathione, the cell’s primary intracellular defence against oxidative damage. ^[1]

Disulfide Bonds and Keratin Structure

The most widely known role of cysteine in skin biology is in the formation of disulfide bonds – covalent linkages between the sulphur atoms of two cysteine residues on adjacent or the same keratin chain. These bonds form when the reducing environment of the hair follicle matrix transitions to the oxidising environment of the keratinising zone as the hair shaft hardens, locks the keratin chains into their final configuration, and gives the mature fibre its mechanical properties. ^[3]

The density and distribution of disulfide bonds directly determines the physical character of keratin. More disulfide bonds per unit length produce harder, more rigid structures – as seen in nails and the innermost cortex of the hair shaft. Fewer bonds, more loosely distributed, produce softer, more flexible structures – the character of the outer cortex of scalp hair. This is why structural diversity within a single hair is possible, and why chemical hair treatments such as perming and relaxing work by deliberately breaking and re-forming disulfide bonds in new configurations: the bonds are covalent enough to hold structure under normal conditions, but chemically addressable under reducing or oxidising conditions. ^[3]

In the epidermis, cysteine-derived disulfide bonds perform the same cross-linking function in the keratin network of corneocytes – contributing to the mechanical toughness of the stratum corneum and the integrity of the cornified envelope that forms the outer boundary of each corneocyte.

Cysteine as Glutathione Precursor

Cysteine’s second major role in skin biology operates through an entirely different mechanism – as the rate-limiting substrate for glutathione (GSH) synthesis. Glutathione is a tripeptide (glutamate–cysteine– glycine) synthesised in two enzymatic steps, and the availability of cysteine determines the rate at which cells can produce it. Fibroblasts and keratinocytes both depend on glutathione for protection against the reactive oxygen species (ROS) generated by UV exposure, environmental pollutants, and metabolic activity. GSH directly scavenges ROS and regenerates other antioxidants including vitamin C and vitamin E after they have donated electrons. ^[2]

The clinical consequence of cysteine shortage on the glutathione system is well-evidenced in skin models. Research using primary human keratinocytes demonstrated that a cysteine derivative (lysine carboxymethyl cysteinate, LCC) capable of penetrating the stratum corneum and reaching the epidermis significantly increased endogenous GSH levels in keratinocytes, protected cells against blue-light-induced oxidative stress, and reduced UVB-induced barrier disruption and pigmentation in a pigmented living skin equivalent model. The same compound reduced inflammatory mediator production, demonstrating that the cysteine-to-glutathione pathway has anti-inflammatory as well as antioxidant consequences in epidermal tissue. ^[2]

Clinical Pearl Glutathione depletion and cysteine shortage do not present as an obvious clinical picture – the effects are subthreshold reductions in cellular repair capacity, increased UV-induced DNA damage accumulation, and reduced inflammatory resolution rather than a visible acute change. This is why cysteine’s relevance to skin ageing and photodamage is best understood at the population level (where lower GSH is associated with more pronounced ageing changes) rather than as an individually visible deficit in most clients.

Cysteine and Hair Follicle Biology

Cysteine’s relevance to hair extends beyond the structural role in the mature fibre. Within the hair follicle matrix – the rapidly dividing cells at the base of the follicle that produce the hair shaft – cysteine availability influences both protein synthesis rate and the oxidative stress environment in which matrix cells divide. Keratin is the most cysteine-rich structural protein in the body, and the matrix cells’ demand for cysteine during the active synthesis phase of anagen is disproportionately high relative to other tissues. ^[5]

N-acetylcysteine (NAC) – a stable, bioavailable form of cysteine used as a supplement – has been examined in several hair loss contexts. In a mouse model of chemotherapy-induced alopecia, NAC co-administration with cyclophosphamide reversed chemotherapy-induced increases in malondialdehyde (a lipid peroxidation marker), preserved follicle structure and melanin distribution, and restored normal p53 and ki67 expression – markers of apoptosis suppression and cell proliferation respectively. The mechanism is primarily antioxidant: chemotherapy generates acute oxidative stress in rapidly dividing cells including matrix cells, and NAC’s glutathione-replenishing effect buffers the follicle against this damage. ^[4]

Research in androgenetic alopecia has proposed that cysteine metabolism disturbances may contribute to ferroptosis – a form of iron-dependent cell death driven by lipid peroxidation – in hair follicle cells, with NAC supplementation hypothesised as a potential mitigating intervention through its glutathione peroxidase 4 (GPX4) activity support. This is currently a mechanistic hypothesis requiring clinical verification rather than an established pathway. ^[5]

Cysteine, Methionine, and Protein Restriction

Because cysteine is synthesised from methionine via the transsulphuration pathway, both amino acids are relevant when protein intake is restricted. Under low methionine conditions – as during caloric restriction, rapid weight loss, or appetite suppression from GLP-1 receptor agonist medications – the body’s capacity to synthesise cysteine declines, simultaneously reducing both the substrate available for keratin synthesis and the precursor pool for glutathione production. Hair and skin quality changes during rapid weight loss therefore have a cysteine-specific dimension alongside the broader amino acid substrate shortage discussed in the parent Amino Acids entity.